Frequently Asked Questions About Eteplirsen (Exondys 51) for DMD Treatment
Let's learn together the answers to the frequently asked questions by Duchenne muscular dystrophy (DMD) patients about Eteplirsen (Exondys 51), which was approved by...
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
A genetic condition known as Duchenne muscular dystrophy (DMD) results in gradual muscle weakening. Boys are more likely to have DMD, with symptoms first...
UK Approves Givinostat (Duvyzat) for Duchenne Muscular Dystrophy Treatment
Givinostat conditionally approved to treat patients with Duchenne muscular dystrophy (DMD).
In a significant development for patients with Duchenne muscular dystrophy (DMD), the Medicines and...
Santhera Announces Approval in Hong Kong for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy
Santhera Pharmaceuticals announces that the Department of Health of Hong Kong, China, has approved AGAMREE® (vamorolone) for use in patients aged 4 years and...
What is Duvyzat (Givinostat)?
For individuals with Duchenne muscular dystrophy (DMD), adults and children six years of age and older, the U.S. has approved the oral treatment duvyzat...